Editorial Comment: Beyond Gastrectomy: Defining the Functional Cost of Perigastric Cytoreduction
Authors:
Open Access
- 12 September 2026
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (12) , 9962-9964
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal OriginJAMA Surgery, 2023
- Treatment of advanced pseudomyxoma peritonei using cytoreductive surgery including total gastrectomy and perioperative chemotherapyJournal of Surgical Oncology, 2021
- The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive SurgeryJAMA Surgery, 2021
- Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical MethodAnnals of Surgical Oncology, 2020
- Perioperative Morbidity of Gastrectomy During CRS-HIPEC: An ACS-NSQIP AnalysisJournal of Surgical Research, 2019
- Advanced Pseudomyxoma Peritonei Requiring Gastrectomy to Achieve Complete Cytoreduction Results in Good Long-Term Oncologic OutcomesAnnals of Surgical Oncology, 2016
- Should total gastrectomy and total colectomy be considered for selected patients with severe tumor burden of pseudomyxoma peritonei in cytoreductive surgery?European Journal of Surgical Oncology, 2016
- Institutional Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal MalignanciesAnnals of Surgical Oncology, 2014
- Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritoneiBritish Journal of Surgery, 2014
- Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyJournal of Clinical Oncology, 2012